Cutera (NASDAQ:CUTR) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Trading Down 63.9 %

NASDAQ CUTR opened at $0.04 on Tuesday. Cutera has a 1-year low of $0.09 and a 1-year high of $3.00. The stock has a 50-day moving average of $0.35 and a 200-day moving average of $0.48. The firm has a market cap of $787,254.00, a PE ratio of -0.01 and a beta of 1.36.

Institutional Investors Weigh In On Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP bought a new stake in Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned about 0.82% of Cutera at the end of the most recent quarter. 90.70% of the stock is currently owned by institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.